Näytetään tulokset 1 - 10 / 11986
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro

Vertaisarvioitu
DOI
10.3109/10428194.2015.1065980
Asadi-Azarbaijani, Babak; Sheikhi, Mona; Nurmio, Mirja; Tinkanen, Helena; Juvonen, Vesa; Dunkel, Leo...
Leukemia & lymphoma2016 Julkaisujen tiedon ikoni

TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/08880018.2020.1842570
Nordic Soc Pediat Hematology Oncol; Dreisig, Karin; Brunner, Emilie Damgaard; Marquart, Hanne V.; He...
Pediatric hematology and oncology2021 Julkaisujen tiedon ikoni

Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia:The NOPHO ALL2008 experience

Vertaisarvioitu
DOI
10.1111/bjh.15761
Ifversen, Marianne; Turkiewicz, Dominik; Marquart, Hanne V.; Winiarski, Jacek; Buechner, Jochen; Mel...
British journal of haematology2019 Julkaisujen tiedon ikoni

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro

Vertaisarvioitu
DOI
10.3109/10428194.2015.1065980
Asadi-Azarbaijani B, Sheikhi M, Nurmio M, Tinkanen H, Juvonen V, Dunkel L, Hovatta O, Oskam IC, Jahn...
Leukemia and Lymphoma2016 Julkaisujen tiedon ikoni

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41375-018-0307-6
S. Modvig, H. O. Madsen, S. M. Siitonen, S. Rosthøj, A. Tierens, V. Juvonen, L.T.N. Osnes, H. Vålerh...
Leukemia2019 Julkaisujen tiedon ikoni

DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/pbc.25958
Borssen, Magnus; Haider, Zahra; Landfors, Mattias; Noren-Nystrom, Ulrika; Schmiegelow, Kjeld; Asberg...
Pediatric blood and cancer2016 Julkaisujen tiedon ikoni

Orthogonal polynomials of the R-linear generalized minimal residual method

Vertaisarvioitu
DOI
10.1016/j.jat.2012.12.007
Huhtanen, Marko; Perämäki, Allan
Journal of approximation theory2013 Julkaisujen tiedon ikoni

Orthogonal polynomials of the R-linear generalized minimal residual method

Vertaisarvioitu
DOI
10.1016/j.jat.2012.12.007
Huhtanen, Marko; Perämäki, Allan
Journal of Approximation Theory2013 Julkaisujen tiedon ikoni

Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/cam4.4218
Al Hamed, Rama; Labopin, Myriam; Daguindau, Etienne; Niittyvuopio, Riitta; Huynh, Anne; Socie, Gerar...
Cancer medicine2022 Julkaisujen tiedon ikoni

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/bcj.2014.69
Silvennoinen, R.; Lundan, T.; Kairisto, V.; Pelliniemi, T-T; Putkonen, M.; Anttila, Pekka; Huotari, ...
Blood cancer journal2014

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro

Vertaisarvioitu
DOI
10.3109/10428194.2015.1065980
2016

TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/08880018.2020.1842570
2021

Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia:The NOPHO ALL2008 experience

Vertaisarvioitu
DOI
10.1111/bjh.15761
2019

Minimal residual disease of leukemia and the quality of cryopreserved human ovarian tissue in vitro

Vertaisarvioitu
DOI
10.3109/10428194.2015.1065980
2016

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41375-018-0307-6
2019

DNA Methylation Adds Prognostic Value to Minimal Residual Disease Status in Pediatric T-Cell Acute Lymphoblastic Leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/pbc.25958
2016

Orthogonal polynomials of the R-linear generalized minimal residual method

Vertaisarvioitu
DOI
10.1016/j.jat.2012.12.007
2013

Orthogonal polynomials of the R-linear generalized minimal residual method

Vertaisarvioitu
DOI
10.1016/j.jat.2012.12.007
2013

Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/cam4.4218
2022

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma.

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/bcj.2014.69
2014